Levels of Inflammatory Markers in the Treatment of Strokeā€”An SPS3 Ancillary Study "LIMITS"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 May 2016.

1 Jun 2005 20 Dec 2007 1 Apr 2012 1 Jan 2017 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts